SCHEMBL25544696

SCHEMBL25544696

N#Cc1ccc(-c2ccc(N(c3ccc(-c4cccc5c4oc4ccccc45)cc3)c3ccc4oc5ccccc5c4c3)cc2)cc1C#N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
PRKDC P78527 6/20 0.34
GGPS1 O95749 1/20 0.34
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 3/20 0.33
PTGES2 Q9H7Z7 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CCNT1 O60563 1/20 0.31
CDK9 P50750 1/20 0.31
TNKS O95271 1/20 0.31
HSP90AA1 P07900 1/20 0.30
HSP90AB1 P08238 1/20 0.30
PIM1 P11309 1/20 0.30
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25548565 0.96 ALOX5 (0.44) ALOX5PRKDCGGPS1ALDH1A1KDM4E
SCHEMBL25544697 0.95 ALOX5 (0.45) ALOX5PRKDCGGPS1ALDH1A1KDM4E
SCHEMBL23328768 0.95 ALOX5 (0.47) ALOX5PRKDCGGPS1ALDH1A1KDM4E
SCHEMBL25544526 0.95 ALOX5 (0.47) ALOX5PRKDCGGPS1ALDH1A1KDM4E
SCHEMBL25543726 0.93 ALOX5 (0.45) ALOX5PRKDCGGPS1ALDH1A1KDM4E
SCHEMBL25543478 0.91 ALOX5 (0.48) ALOX5PRKDCGGPS1ALDH1A1KDM4E
SCHEMBL25546983 0.91 ALOX5 (0.48) ALOX5PRKDCGGPS1ALDH1A1KDM4E
SCHEMBL25544623 0.91 ALOX5 (0.44) ALOX5PRKDCGGPS1ALDH1A1KDM4E
SCHEMBL25543719 0.90 ALOX5 (0.45) ALOX5PRKDCGGPS1ALDH1A1KDM4E
SCHEMBL23328492 0.90 ALDH1A1 (0.39) ALDH1A1KDM4EMEN1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-09-21 US disclosed
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-09-21 US disclosed
EP-4183784-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME Lapto Co., Ltd. (KR) 2023-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME SAT1, FTO, SETDB1 ALOX5 2036/4885PRKDC 2559/4885GGPS1 3576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.